Skip to main content

Clinical

RSS  

Articles

  • Draw the circle wide to add contraceptive ring

    When reviewing contraceptive options with patients, what information do you provide on the vaginal contraceptive ring (NuvaRing, Organon USA, Roseland, NJ). Recent information indicates that vaginal administration of contraceptive hormones can result in lower doses, steady drug levels, and less frequent administration than the oral route.
  • Time to take aim at treating trichomoniasis

    While trichomoniasis is the most common curable sexually transmitted disease (STD) in the United States,1 reports of metronidazole-resistant trichomoniasis are increasing. New evidence indicates that tinidazole (Tindamax, Presutti Laboratories, Rolling Meadows, IL), recently introduced in the United States, is an effective therapy for metronidazole-resistant trichomoniasis and is well tolerated even at high doses.
  • Washington Watch: Health plans proposal poses access problems

    The Bush administration and conservative members of Congress are touting legislation to create Association Health Plans (AHPs) as one of their answers to the growing problem of the nations uninsured, which totaled 45 million in 2003. These plans would allow professional and trade associations to band together to use their heightened purchasing power to offer insurance coverage to their members.
  • Enter nominations now for clinician award

    Nominations are being accepted for the Inspirations in Womens Health contest, sponsored by the Washington, DC-based National Association of Nurse Practitioners in Womens Health (NPWH) and the St. Paul, MN-based 3M Pharmaceuticals. The contest recognizes nurse practitioners who go above and beyond the call of duty in the areas of womens reproductive and sexual health.
  • Update: Today contraceptive sponge returns to U.S. drugstore shelves

    Women who have been waiting for news of the Today contraceptive sponges re-emergence on U.S. market shelves can relax; the popular over-the-counter contraceptive should return to drugstore shelves this summer following the Food and Drug Administrations (FDAs) recent approval of the sponges manufacturing facility.
  • Bad News About the COX-2 Inhibitors

    There has been enormous controversy regarding the benefit/safety relationship of the COX-2 inhibitors, which were initially introduced in 1999. Recent issues of the New England Journal of Medicine contain numerous articles (3 original reports, 2 editorials) that deal with this complex and unhappy story.
  • Outcomes in Asymptomatic Mitral Regurgitation

    Quantitating mitral regurgitation by echocardiography predicts clinical outcomes and those with an EROA of at least 40 mm2 should be considered for surgery.
  • Intramural Hematoma of the Aorta

    There is a 6% incidence of IMH among patients presenting as acute aortic syndromes and it is as lethal as AD, especially in the ascending aorta and, thus, surgery should be considered for patients with type A IMH.
  • Catheter Ablation for Atrial Fibrillation

    The data provide a picture of the evolving status of catheter ablation of atrial fibrillation in the period of 1995 through 2002.
  • Transtelephonic ECG Monitoring for Detecting Arrhythmia Recurrences After Radiofrequency Ablation

    Routine daily transtelephonic ECG monitoring detects often asymptomatic arrhythmia episodes in a significant proportion of patients after radiofrequency ablation.